This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) | MicrobiomeTrials
← Back to trials NCT03157128
A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) Recruiting PHASE1, PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2017-05-02Est. Completion: 2025-02-14
Enrollment target: 857 participantsLocations Mayo Clinic of Scottsdale, Scottsdale, Arizona, United States City of Hope National Medical Center, Duarte, California, United States UCLA Medical Center, Los Angeles, California, United States Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States Kaiser Permanente, Oakland, California, United States Irvine Medical Center, Orange, California, United States University of California - San Diego, San Diego, California, United States UCSF Medical Center at Mission Bay, San Francisco, California, United States Kaiser Permanente Medical Center, Walnut Creek, California, United States Sarah Cannon Research Institute at HealthOne, Denver, Colorado, United States Yale Cancer Center, New Haven, Connecticut, United States Mayo Clinic in Florida, Jacksonville, Florida, United States Memorial Hospital Pembroke, Pembroke, Florida, United States Emory University, Atlanta, Georgia, United States University of Chicago Medicine-Comprehensive Cancer Center, Chicago, Illinois, United States Other microbiome trials you might be interested in Non Squamous Non Small Cell Lung Cancer
This is a randomized, multicenter, multinational, double-blind, integrated pharmacokinetics (PK) and efficacy similarity…
Yerevan, Armenia Est. completion Aug 31, 2026
Lung Non-Small Cell Carcinoma Stage IV Lung Cancer AJCC v8
This phase II trial tests how well biologically guided radiation therapy (BgRT) and stereotactic body radiation therapy …
Duarte, United States Completed Mar 9, 2027
Ochsner Clinic Foundation, New Orleans, Louisiana, United States
University of Maryland Medical Center, Baltimore, Maryland, United States
Johns Hopkins University, Baltimore, Maryland, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
University of Michigan, Ann Arbor, Michigan, United States
START Midwest, Grand Rapids, Michigan, United States
Mayo Clinic, Rochester, Minnesota, United States
Washington University Medical School, St Louis, Missouri, United States
Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
NYU Langone, New York, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
University of North Carolina, Chapel Hill, North Carolina, United States
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Ohio State University Hospital, Columbus, Ohio, United States
Oregon Health and Science University, Portland, Oregon, United States
University of Pennsylvania Hospital, Philadelphia, Pennsylvania, United States
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Sarah Cannon Research Institute SCRI, Nashville, Tennessee, United States
Vanderbilt University Medical Center, Nashville, Tennessee, United States
University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Huntsman Cancer Institute, Salt Lake City, Utah, United States
USO-Virginia Cancer Specialists, PC, Fairfax, Virginia, United States
University of Wisconsin-Madison Hospital and Health Clinic, Madison, Wisconsin, United States
Royal North Shore Hospital, St Leonards, New South Wales, Australia
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
BC Cancer Vancouver, Vancouver, British Columbia, Canada
Rigshospitalet, Copenhagen, Denmark
Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest, Bordeaux, Aquitaine, France
Centre Leon Berard, Lyon, Auvergne-Rhône-Alpes, France
APHM Hôpital de la Timone, Marseille, France
Institut du Cancer de Montpellier - Val d'aurelle, Montpellier, France
Gustave Roussy, Villejuif, France
Hôpital Européen Georges Pompidou, Paris, Île-de-France Region, France
Universitätsklinikum Würzburg A. ö. R., Würzburg, Bavaria, Germany
Universitätsklinikum Köln, Cologne, North Rhine-Westphalia, Germany
Prince of Wales Hospital, Hong Kong, Shatin, New Territories, Hong Kong
Sheba Medical Center, Ramat Gan, Central District, Israel
Shaare Zedek Medical Center, Jerusalem, Jerusalem, Israel
Soroka Medical Center - Pediatric Outpatient Clinic, Beersheba, Israel
Hadassah Medical Center, Jerusalem, Israel
Istituto Nazionale dei Tumori, Milan, Lombardy, Italy
Nagoya University Hospital, Nagoya, Aichi-ken, Japan
National Cancer Center Hospital East, Kashiwa, Chiba, Japan
Hokkaido University Hospital, Sapporo, Hokkaido, Japan
Hyogo Cancer Center, Akashi, Hyōgo, Japan
Kanazawa University Hospital, Kanazawa, Ishikawa-ken, Japan
Kindai University Hospital, Osaka Sayama-shi, Osaka, Japan
Tominaga Hospital, Nagaizumi-cho,Sunto-gun, Shizuoka, Japan
National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
Japanese Foundation for Cancer Research, Koto, Tokyo, Japan
Tottori University Hospital, Yonago, Tottori, Japan
National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
Okayama University Hospital, Okayama, Japan
Osaka City General Hospital, Osaka, Japan
National Cancer Centre Singapore, Singapore, Central Singapore, Singapore
National Cancer Center, Goyang-si, Kyǒnggi-do, South Korea
Seoul National University Bundang Hospital, Seongnam, Kyǒnggi-do, South Korea
Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Samsung Medical Center, Seoul, South Korea
Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona], Spain
Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Hospital Madrid Norte Sanchinarro, Madrid, Spain
Kantonsspital Luzern, Lucerne, Canton of Lucerne, Switzerland
Taichung Veterans General Hospital, Taichung, Taiwan
National Taiwan University Hospital, Taipei, Taiwan
Royal Marsden Hospital, London, United Kingdom Epidermal Growth Factor Epidermal Growth Factor Receptor Epidermal Growth Factor Receptor Gene Mutation Non Small Cell Non Small Cell Lung Non Small Cell Lung Cancer Head and Neck Head and Neck Cancer Head and Neck Cancers Head and Neck Squamous Cell Cancer Head and Neck Squamous Cell Carcinoma Head and Neck Squamous Cell Carcinoma HNSCC NSCLC (Non-small Cell Lung Cancer) HNSCC EGFR
A phase 1 study to determine the safety, tolerability, PK, PD, and preliminary anti-tumor activity of ascending doses of…
Los Angeles, United States Est. completion Jul 2029